Biomerica, Inc. (BMRA) vs Co-Diagnostics, Inc. (CODX)

A side-by-side comparison of Biomerica, Inc. and Co-Diagnostics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BMRA vs CODX

growth of $100 · dividends reinvested · last 9y
BMRA -90.1% (-22.6%/yr)CODX -99.4% (-43.0%/yr)BMRA compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $1002019202120232025$10$1
BMRA CODX

BMRA vs CODX: by the numbers

  • •CODX is the larger company ($7M vs $7M market cap).
  • •Both run net losses; BMRA's is the smaller (-84.79% vs -6523.04% net margin).
  • •Both shrank revenue over the past five years; BMRA's decline was smaller (-9.17% vs -62.43% CAGR).

Metrics side by side

Valuation

MetricBMRACODX
P/S ratio1.499.97
P/B ratio2.510.57

Profitability

MetricBMRACODX
Gross margin8.09%64.28%
Operating margin-119.54%-5025.53%
Net margin-84.79%-6523.04%
ROE-143.54%-370.16%
ROIC-117.93%-219.15%

Growth (annualized)

MetricBMRACODX
Revenue CAGR (5Y)-9.17%-62.43%
Total return CAGR (5Y)-46.66%-66.53%

Frequently asked

Which has grown faster, BMRA or CODX?
Neither grew: over the past five years both shrank revenue, with BMRA's decline the smaller — BMRA at a -9.17% CAGR versus CODX at -62.43%.
How have BMRA and CODX total returns compared?
Over the past 5 years, BMRA delivered -46.66% and CODX delivered -66.53% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.